P. Ott

Oncology · 2013–2021

A researcher in the Science corpus: 13 papers; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.

Subfields

Whom P. Ott trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. S. Topalian
  2. Antoni Ribas
  3. F. Hodi
  4. D. Pardoll
  5. C. Robert
  6. D. Gabrilovich
  7. S. Rosenberg

Who trusts P. Ott overall

  1. E. Buchbinder

Papers from P. Ott's perspective

Ordered by how strongly the researchers P. Ott trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice. (Science)
  2. Blockade of CTLA-4 on both effector and regulatory T cell compartments contributes to the antitumor activity of anti–CTLA-4 antibodies (Journal of Experimental Medicine)
  3. VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing. (Genome Research)
  4. Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion (Nature Medicine)
  5. Pembrolizumab for the treatment of non-small-cell lung cancer. (New England Journal of Medicine)
  6. Cancer Regression in Patients After Transfer of Genetically Engineered Lymphocytes (Science)
  7. Colocalization of Inflammatory Response with B7-H1 Expression in Human Melanocytic Lesions Supports an Adaptive Resistance Mechanism of Immune Escape (Science Translational Medicine)
  8. The future of immune checkpoint therapy (Science)
  9. Biologic activity of cytotoxic T lymphocyte-associated antigen 4 antibody blockade in previously vaccinated metastatic melanoma and ovarian carcinoma patients (Proceedings of the National Academy of Sciences of the United States of America)
  10. Sequenza: allele-specific copy number and mutation profiles from tumor sequencing data (Annals of Oncology)

Their papers